Results 61 to 70 of about 10,641 (185)

Parasomnias and sleep‐related movement disorders induced by drugs in the adult population: a review about iatrogenic medication effects

Journal of Sleep Research, Volume 34, Issue 2, April 2025.
Summary Parasomnias and sleep‐related movement disorders (SRMD) are major causes of sleep disorders and may be drug induced. The objective of this study was to conduct a systematic review of the literature to examine the association between drug use and the occurrence of parasomnias and SRMD.
Sylvain Dumont, Vanessa Bloch, Agnès Lillo‐Lelouet, Christine Le Beller, Pierre A. Geoffroy, Marc Veyrier   +5 more
wiley   +1 more source

Multimodal treatment for smoking cessation with varenicline in alcoholic, methadone-maintained, and psychotic patients: A one-year follow-up

, 2018
Introduction Numerous studies have evaluated the efficacy and safety of varenicline for smoking cessation in smokers in the general population and, to a lesser extent, among the psychiatric population.
Silvia Mondon, on behalf of the Tobacco Group of the Catalan Network for Addiction Treatment*, Antonia Raich, Esteve Fernández, Montse Ballbè, Rosa Tejedor, Cristina Pinet, Anna Arnau   +7 more
core   +1 more source

Nicotine receptor partial agonists for smoking cessation

São Paulo Medical Journal
BACKGROUND: Nicotine receptor partial agonists may help people to stop smoking by a combination of maintaining moderate levels of dopamine to counteract withdrawal symptoms (acting as an agonist) and reducing smoking satisfaction (acting as an antagonist)
Kate Cahill, Lindsay F. Stead, Tim Lancaster, Igor Bastos Polonio   +3 more
doaj   +1 more source

Varenicline versus nicotine replacement therapy for long-term smoking cessation: an observational study using the Clinical Practice Research Datalink

Health Technology Assessment, 2020
Background: Smoking is the leading avoidable cause of illness and premature mortality. The first-line treatments for smoking cessation are nicotine replacement therapy and varenicline.
Neil M Davies, Amy E Taylor, Gemma MJ Taylor, Taha Itani, Tim Jones, Richard M Martin, Marcus R Munafò, Frank Windmeijer, Kyla H Thomas   +8 more
doaj   +1 more source

An integrated behavioral change model for smoking cessation in periodontal care: The four‐stage behavioral support staircase

Periodontology 2000, EarlyView.
Abstract Objectives Smoking tobacco is a critical modifiable risk factor for periodontal and peri‐implant diseases. This narrative review integrates established behavioral theories with communication‐based psychological processes to propose an evidence‐based model for smoking cessation support in periodontal care.
Christoph A. Ramseier
wiley   +1 more source

The effect of varenicline on binge-like ethanol consumption in mice is beta4 nicotinic acetylcholine receptor-independent [PDF]

, 2016
BACKGROUND: \ud \ud Our laboratory has previously shown that the smoking-cessation agent varenicline, an agonist/partial agonist of alpha4beta2*, alpha3beta4*, alpha3beta2*, alpha6beta2* (* indicates the possibility of additional subunits) and alpha7 ...
Bartlett, Selena E., Patkar, Omkar L., Belmer, Arnauld, Holgate, Joan Y., Tarren, Josephine R.   +4 more
core   +1 more source

Unannounced telephone pill counts for assessing varenicline adherence in a pilot clinical trial

, 2011
Nia Thompson1, Niaman Nazir1, Lisa Sanderson Cox1,2, Babalola Faseru1,2, Kathy Goggin3, Jasjit S Ahluwalia4, Nicole L Nollen1,21University of Kansas School of Medicine, Department of Preventive Medicine and Public Health, Kansas City, KS, USA ...
Faseru B, Sanderson Cox L, Babalola Faseru, Nazir N, Kathy Goggin, Ahluwalia JS, null Cox, Thompson N, Nia Thompson, Jasjit Ahluwalia, Niaman Nazir, Nicole Nollen, Nollen NL, Goggin K   +13 more
core   +1 more source

Combination therapy assessment with varenicline.

, 2014
One known and two new potential synergistic interactions with varenicline have been identified. Bupropion and topiramate show a positive interaction with varenicline using Bliss Independence analysis.
Jon O. Ebbert (540776), Mark D. Urban (540778), Stephen C. Ekker (10102), Eric W. Klee (10099), David P. Argue (540779), Margot A. Cousin (540775), Amanda R. Wiinamaki (540777)   +6 more
core   +1 more source

Smoking cessation therapy with varenicline

, 2008
Uma M Mohanasundaram, Rajinder Chitkara, Ganesh KrishnaDivision of Pulmonary and Critical Care Medicine, Department of Medicine, Stanford University School of Medicine, CA, USAAbstract: Smoking cessation is the only available intervention proven to halt ...
Ganesh Krishna, Rajinder Chitkara, Uma M Mohanasundaram   +2 more
core  

Awareness and early implementation of the European AIDS Clinical Society Guidance on statin use in HIV for the primary prevention of cardiovascular disease: A cross‐sectional survey of HIV clinicians in Europe

HIV Medicine, Volume 27, Issue 9, Page 1537-1547, September 2026.
Abstract Objectives Cardiovascular disease (CVD) is a major comorbidity and leading cause of morbidity and mortality in people with HIV (PWH). The REPRIEVE trial demonstrated that statin therapy significantly reduces cardiovascular events in PWH, prompting updated recommendations from major international societies.
Jasmini Alagaratnam, Abiu Sempere, Susanne Dam Nielsen, Esteban Martinez   +3 more
wiley   +1 more source